Pfizer Inc PFE

$27.57 -0.49 (-1.75%)

Valuation

Market cap
162,274,848,000
Revenue TTM
$62,579,000,000
Net income TTM
$7,771,000,000
P/E (trailing)
9.46
P/E (forward)
9.48
Profit margin
12.42%
Debt to equity
0.70

Trading

Volume
27,070,084
Avg volume
33,660,148
Day's range
$27.44 – $27.99
Shares out
5,699,854,000
Stochastic %K
3%
Beta
0.31
Analysts
Hold
Price target
$30.56

Price

Company profile

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under...

Show more

Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products in the United States and internationally. It operates in three segments: Biopharma, PC1, and Pfizer Ignite. The company offers internal medicine products, including cardiovascular metabolic diseases products under the Eliquis brand; migraine products under the Nurtec ODT/Vydura and Zavzpret brand; vaccines under the Prevnar family, Abrysvo, Nimenrix, FSME/IMMUN-TicoVac, and Trumenba brands; and Paxlovid for the treatment of COVID-19. It also provides inflammation and immunology products, such as Xeljanz, Enbrel, Cibinqo, Litfulo, Eucrisa, and Velsipity; rare disease products for therapeutic areas comprising amyloidosis, hemophilia, and endocrine diseases under the Vyndaqel family, Genotropin, BeneFIX, Xyntha, Somavert, Ngenla, and Hympavzi brands; and anti-infective and immunoglobulin medicines under the Zavicefta, Octagam, and Panzyga brands. In addition, the company offers oncology products comprising ADCs, small molecules, bispecific, and other immunotherapies for the treatment of cancers, including breast cancer, genitourinary cancer, and hematologic malignancies, as well as melanoma, gastrointestinal, gynecological, and lung cancer under the Ibrance, Xtandi, Padcev, Adcetris, Inlyta, Lorbrena, Bosulif, Tukysa, Braftovi, Mektovi, Orgovyx, Elrexfio, Tivdak, and Talzenna brands. Further, it provides biosimilars under the Inflectra brand; oncology biosimilars comprising Retacrit, Ruxience, Zirabev, Trazimera and Nivestym, and other biosimilars; and sterile injectables, such as Sulperazon, Atgam, Fragmin, Solu Medrol, Solu Cortef, and Bicillin. The company has collaboration agreements with Bristol-Myers Squibb Company; Astellas Pharma US, Inc.; Merck KGaA; and BioNTech SE, as well as a strategic collaboration with Boltz, PBC to develop and deploy biomolecular AI foundation models. Pfizer Inc. was founded in 1849 and is headquartered in New York, New York.

Industry
Drug Manufacturers - General
Sector
Healthcare
Phone
212 733 2323
Website
https://www.pfizer.com
Address
66 Hudson Boulevard East, New York, United States

Latest news

Stocktwits

GridironGainz Nov 19, 8:50 PM 0 replies
karpy Nov 19, 8:45 PM 0 replies
nimii Nov 19, 8:13 PM
$PFE 😡🤬😾
0 replies
openclassaction2 Nov 19, 7:42 PM
$PFE the $44 million chantix settlement awaits final approval, per open class actions. suit alleged an undisclosed nitrosamine impurity. claims closed sept 14. even pharma pays for the boom years
0 replies
ItsCarRamRod Nov 19, 7:38 PM
$PFE this should retest the $24 bottom
0 replies
dom04 Nov 19, 5:52 PM
$PFE come on you donkey!
0 replies
RookyMoves Nov 19, 5:37 PM
$PFE fair chance this is last stop on the way back up. Looking for support at the 20wk.
0 replies
markarchibald Nov 19, 4:53 PM
$PFE StO 1x 12/18 30/CC for.16
0 replies